On May 12, 2025, the Centers for Medicare & Medicaid Services (CMS) issued draft guidance for the third cycle of the IRA’s Medicare Drug Price Negotiation Program (Negotiation Program). This draft ...

In April 2025, the Centers for Medicare and Medicaid Services (“CMS”) issued multiple pieces of guidance related to Medicare Advantage plans and Medicare Part D prescription drug coverage, including ...

The enterprise-grade workflow automation solution expands Plenful’s Regulatory Compliance and Revenue Optimization suite with powerful reconciliation tools, giving pharmacy, revenue cycle, and finance ...

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.

PHILADELPHIA, PA, UNITED STATES, February 4, 2026 /EINPresswire.com/ — RxParadigm, an end-to-end 340B drug administration platform with integrated capabilities to ...

Medicare’s Maximum Fair Price (MFP) officially went live on January 1st. Select Medicare Part D drugs are now subject to negotiated pricing under the Inflation Reduction Act, with 15 additional Part D ...

Currently in the final testing and certification stages with CMS, RxParadigm will soon allow dispensing entities to enroll in the MTF and select RxParadigm as their TPSE. By doing so, entities gain a ...